PCNA and neoplasm: Moreover, IHC analysis revealed a notable decrease in the expression of proliferative proteins Ki67 and PCNA in ACADL overexpressing tumor tissues, which was partially reversed in the XMU-MP-1 treatment group (Fig. 8c and d).